Compassionate use of bedaquiline in the treatment of pulmonary XDR-TB

Int J Tuberc Lung Dis. 2014 Dec;18(12):1522-3. doi: 10.5588/ijtld.14.0338.

Authors

Mauricio Danckers¹, Melissa B Lesko¹, Rosemary Adamson², Eric Leibert¹

Affiliations

¹ Division of Pulmonary, Critical Care and Sleep Medicine, New York University School of Medicine, New York, NY, USA.
² Division of Pulmonary, and Critical Care Medicine, University of Washington, Seattle, WA USA. mauriciodanckers@hotmail.com.

PMID: 25517823
DOI: 10.5588/ijtld.14.0338

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antitubercular Agents / adverse effects
Antitubercular Agents / therapeutic use*
Compassionate Use Trials*
Diarylquinolines / adverse effects
Diarylquinolines / therapeutic use*
Drug Substitution
Drug Therapy, Combination
Extensively Drug-Resistant Tuberculosis / diagnosis
Extensively Drug-Resistant Tuberculosis / drug therapy*
Humans
Male
Tomography, X-Ray Computed
Treatment Outcome
Tuberculosis, Pulmonary / diagnosis
Tuberculosis, Pulmonary / drug therapy*

Substances

Antitubercular Agents
Diarylquinolines
bedaquiline